LiWChenXXieXXuMXuLLiuPet alComparison of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide receptor agonists for atrial fibrillation in type 2 diabetes Mellitus: systematic review with network meta-analysis of randomized controlled trials
10.1055/s-2004-815490 194 ZhangY.AkaoT.NakamuraN.HattoriM.YangX
Why healing becomes harder on GLP-1s Several factors contribute to healing challenges while taking Ozempic or similar medications: Reduced caloric intake: GLP-1 agonists dramatically decrease appetite
In one study, 305 patients with gastroparesis had their dietary intake and nutritional status evaluated, and the average caloric intake was 1168 kcal/day, which resulted in substantial nutritional deficiencies
honestly I am not thrashing GLP-1 meds for a lot of people when prescribed and monitored, they help improve health, fitness, quality of life, but the marketing of them preys on women's insecurities in a very sinister way
Food and Drug Administration (FDA), under the Federal Food, Drug, and Cosmetic Act (FD&C Act), regulates GLP-1 receptor agonists
